Company’s 36-month beta value is 0.85.Analysts have differing opinions on the stock, with 0 analysts rating it as a “buy,” 0 as “overweight,” 0 as “hold,” and 0 as “sell.”
The public float for NNVC is 15.07M, and currently, short sellers hold a 0.87% ratio of that floaft. The average trading volume of NNVC on May 16, 2025 was 144.02K shares.
NNVC) stock’s latest price update
NanoViricides Inc (AMEX: NNVC)’s stock price has increased by 9.37 compared to its previous closing price of 1.31. However, the company has seen a 8.55% increase in its stock price over the last five trading sessions. proactiveinvestors.com reported 2025-05-16 that NanoViricides (NYSE-A:NNVC) is preparing a Phase II clinical trial application for its lead antiviral candidate NV-387 to treat Mpox infections in Central Africa, marking a major step in the company’s broader strategy to address a growing range of viral public health threats with no currently approved treatments. The Connecticut-based biotech firm recently received clearance from the Democratic Republic of Congo’s National Ethics Committee to proceed with the submission following a review of Phase I safety data and promising results from preclinical Mpox studies in lethal animal models.
NNVC’s Market Performance
NanoViricides Inc (NNVC) has seen a 8.55% rise in stock performance for the week, with a 2.34% gain in the past month and a 6.13% surge in the past quarter. The volatility ratio for the week is 7.11%, and the volatility levels for the past 30 days are at 6.76% for NNVC. The simple moving average for the last 20 days is 8.38% for NNVC stock, with a simple moving average of 0.06% for the last 200 days.
Analysts’ Opinion of NNVC
Many brokerage firms have already submitted their reports for NNVC stocks, with Midtown Partners repeating the rating for NNVC by listing it as a “Strong Buy.” The predicted price for NNVC in the upcoming period, according to Midtown Partners is $5.30 based on the research report published on February 11, 2015 of the previous year 2015.
NNVC Trading at 13.97% from the 50-Day Moving Average
After a stumble in the market that brought NNVC to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -60.09% of loss for the given period.
Volatility was left at 6.76%, however, over the last 30 days, the volatility rate increased by 7.11%, as shares surge +9.02% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +9.85% upper at present.
During the last 5 trading sessions, NNVC rose by +9.85%, which changed the moving average for the period of 200-days by -28.57% in comparison to the 20-day moving average, which settled at $1.3229. In addition, NanoViricides Inc saw 0.20% in overturn over a single year, with a tendency to cut further gains.
Stock Fundamentals for NNVC
The total capital return value is set at -1.12. Equity return is now at value -99.84, with -90.50 for asset returns.
Currently, EBITDA for the company is -7.76 million with net debt to EBITDA at 0.28. The liquidity ratio also appears to be rather interesting for investors as it stands at 2.27.
Conclusion
In a nutshell, NanoViricides Inc (NNVC) has experienced a better performance in recent times. The stock has received mixed “buy” and “hold” ratings from analysts. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
